Status:
COMPLETED
Pain Increases After Shoulder Injection
Lead Sponsor:
Campbell Clinic
Conditions:
Shoulder Pain
Eligibility:
All Genders
18-99 years
Phase:
PHASE4
Brief Summary
Compare FLARE reactions (increase in VAS by two or more points) in the first 48 hours following a shoulder injection.
Detailed Description
Corticosteroid injections are used to reduce pain and inflammation for various shoulder pathologies. Corticosteroid flare reaction is a well-described phenomenon that, despite being self-limited, caus...
Eligibility Criteria
Inclusion
- Subacromial or glenohumeral shoulder pain to be treated with steroid injection
- Fluent in written and oral English
- Willing and able to provide written consent
- Willing to complete follow up pain scores (visual analog score)
Exclusion
- Unable to provide written consent
- Chronic pain syndrome
- Unwilling to complete follow up pain scores (visual analog score)
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
421 Patients enrolled
Trial Details
Trial ID
NCT05438277
Start Date
January 1 2020
End Date
September 30 2022
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Campbell Clinic
Germantown, Tennessee, United States, 38138